Children treated with recombinant human growth hormone were found to be at increased risk for cardiovascular events during early adulthood.
The designation is based on positive topline data from a phase 2 study of 120 adults following open-heart surgery.
In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
As cardiorespiratory fitness declines among US youth, researchers explore methods for assessing cardiorespiratory fitness in otherwise healthy children.
Cardiac injury and shock can occur in pediatric patients with COVID-19.
The American College of Cardiology has released guidance on pediatric return-to-play for sports participation following COVID-19 infection.
For anti-SSA/Ro-positive mothers with a previous pregnancy complicated by congenital heart block (CHB), hydroxychloroquine may reduce the recurrence of CHB.
Researchers evaluated blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus.
Higher blood pressure is connected to narrowing of retinal arterioles in young children.
Changes have been suggested for the newborn critical congenital heart disease (CCHD) screening algorithm.